| Dr David J Patton, MD | |
|
108 Washington St W Ste 101, Charleston, WV 25302-2344 | |
| (304) 345-4525 | |
| (304) 345-4527 |
| Full Name | Dr David J Patton |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 108 Washington St W Ste 101, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730289513 | NPI | - | NPPES |
| 0093821000 | Medicaid | WV | |
| P00358615 | Other | WV | RAILROAD MEDICARE |
| CJ5038 | Other | WV | RAILROAD MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 18950 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charleston Area Medical Center | Charleston, WV | Hospital |
| St Francis Hospital | Charleston, WV | Hospital |
| Thomas Memorial Hospital | South charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| David J. Patton, Md., Inc. | 3577620277 | 8 |
News Archive
"The developing world needs support for low-tech health innovations that do not compromise on effectiveness," journalist Priya Shetty writes in this SciDev.Net opinion piece, adding that, against the backdrop of global economic recession and shrinking research and development (R&D) budgets in many developing countries, "a new movement of 'frugal science' is taking hold, in which researchers are hunting for the most cost-effective health technologies for developing countries."
Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.
Following the announcement on Monday that 13 pharmaceutical companies, several large non-profit organizations, governments, and U.N. agencies are joining forces to fight neglected tropical diseases (NTDs), Al Jazeera's "Inside Story" interviewed several experts in the field, asking, "Why have these diseases been neglected for so long? And how effective will the new plans be to counter these diseases and, in turn, alleviate poverty? Is the target date of 2020 set by the initiative realistic to wipe out some of the world's deadliest conditions? And what is in it for them?" according to the show's summary.
Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.
Instead of tackling tumors head-on, an international team of researchers from the University of Geneva and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening with cellular receptor that is overexpressed specifically in cancer blood vessels.
› Verified 2 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194759290 PECOS PAC ID: 4587568134 Enrollment ID: O20031125000177 |
News Archive
"The developing world needs support for low-tech health innovations that do not compromise on effectiveness," journalist Priya Shetty writes in this SciDev.Net opinion piece, adding that, against the backdrop of global economic recession and shrinking research and development (R&D) budgets in many developing countries, "a new movement of 'frugal science' is taking hold, in which researchers are hunting for the most cost-effective health technologies for developing countries."
Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.
Following the announcement on Monday that 13 pharmaceutical companies, several large non-profit organizations, governments, and U.N. agencies are joining forces to fight neglected tropical diseases (NTDs), Al Jazeera's "Inside Story" interviewed several experts in the field, asking, "Why have these diseases been neglected for so long? And how effective will the new plans be to counter these diseases and, in turn, alleviate poverty? Is the target date of 2020 set by the initiative realistic to wipe out some of the world's deadliest conditions? And what is in it for them?" according to the show's summary.
Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.
Instead of tackling tumors head-on, an international team of researchers from the University of Geneva and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening with cellular receptor that is overexpressed specifically in cancer blood vessels.
› Verified 2 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1740450089 PECOS PAC ID: 4587568134 Enrollment ID: O20080807000128 |
News Archive
"The developing world needs support for low-tech health innovations that do not compromise on effectiveness," journalist Priya Shetty writes in this SciDev.Net opinion piece, adding that, against the backdrop of global economic recession and shrinking research and development (R&D) budgets in many developing countries, "a new movement of 'frugal science' is taking hold, in which researchers are hunting for the most cost-effective health technologies for developing countries."
Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.
Following the announcement on Monday that 13 pharmaceutical companies, several large non-profit organizations, governments, and U.N. agencies are joining forces to fight neglected tropical diseases (NTDs), Al Jazeera's "Inside Story" interviewed several experts in the field, asking, "Why have these diseases been neglected for so long? And how effective will the new plans be to counter these diseases and, in turn, alleviate poverty? Is the target date of 2020 set by the initiative realistic to wipe out some of the world's deadliest conditions? And what is in it for them?" according to the show's summary.
Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.
Instead of tackling tumors head-on, an international team of researchers from the University of Geneva and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening with cellular receptor that is overexpressed specifically in cancer blood vessels.
› Verified 2 days ago
| Entity Name | David J. Patton, Md., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063659134 PECOS PAC ID: 3577620277 Enrollment ID: O20091015000244 |
News Archive
"The developing world needs support for low-tech health innovations that do not compromise on effectiveness," journalist Priya Shetty writes in this SciDev.Net opinion piece, adding that, against the backdrop of global economic recession and shrinking research and development (R&D) budgets in many developing countries, "a new movement of 'frugal science' is taking hold, in which researchers are hunting for the most cost-effective health technologies for developing countries."
Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.
Following the announcement on Monday that 13 pharmaceutical companies, several large non-profit organizations, governments, and U.N. agencies are joining forces to fight neglected tropical diseases (NTDs), Al Jazeera's "Inside Story" interviewed several experts in the field, asking, "Why have these diseases been neglected for so long? And how effective will the new plans be to counter these diseases and, in turn, alleviate poverty? Is the target date of 2020 set by the initiative realistic to wipe out some of the world's deadliest conditions? And what is in it for them?" according to the show's summary.
Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.
Instead of tackling tumors head-on, an international team of researchers from the University of Geneva and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening with cellular receptor that is overexpressed specifically in cancer blood vessels.
› Verified 2 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770745036 PECOS PAC ID: 4587568134 Enrollment ID: O20190806002319 |
News Archive
"The developing world needs support for low-tech health innovations that do not compromise on effectiveness," journalist Priya Shetty writes in this SciDev.Net opinion piece, adding that, against the backdrop of global economic recession and shrinking research and development (R&D) budgets in many developing countries, "a new movement of 'frugal science' is taking hold, in which researchers are hunting for the most cost-effective health technologies for developing countries."
Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.
Following the announcement on Monday that 13 pharmaceutical companies, several large non-profit organizations, governments, and U.N. agencies are joining forces to fight neglected tropical diseases (NTDs), Al Jazeera's "Inside Story" interviewed several experts in the field, asking, "Why have these diseases been neglected for so long? And how effective will the new plans be to counter these diseases and, in turn, alleviate poverty? Is the target date of 2020 set by the initiative realistic to wipe out some of the world's deadliest conditions? And what is in it for them?" according to the show's summary.
Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.
Instead of tackling tumors head-on, an international team of researchers from the University of Geneva and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening with cellular receptor that is overexpressed specifically in cancer blood vessels.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David J Patton, MD 108 Washington St W Ste 101, Charleston, WV 25302-2344 Ph: (304) 345-4525 | Dr David J Patton, MD 108 Washington St W Ste 101, Charleston, WV 25302-2344 Ph: (304) 345-4525 |
News Archive
"The developing world needs support for low-tech health innovations that do not compromise on effectiveness," journalist Priya Shetty writes in this SciDev.Net opinion piece, adding that, against the backdrop of global economic recession and shrinking research and development (R&D) budgets in many developing countries, "a new movement of 'frugal science' is taking hold, in which researchers are hunting for the most cost-effective health technologies for developing countries."
Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.
Following the announcement on Monday that 13 pharmaceutical companies, several large non-profit organizations, governments, and U.N. agencies are joining forces to fight neglected tropical diseases (NTDs), Al Jazeera's "Inside Story" interviewed several experts in the field, asking, "Why have these diseases been neglected for so long? And how effective will the new plans be to counter these diseases and, in turn, alleviate poverty? Is the target date of 2020 set by the initiative realistic to wipe out some of the world's deadliest conditions? And what is in it for them?" according to the show's summary.
Coloplast announced today that it has acquired Mpathy Medical, a fast growing company in women's health, for a total cash consideration of USD 30m equal to DKK162m, potentially increasing to a total of USD 35m equal to DKK 189m on a cash and debt free basis. The acquisition expands the Coloplast female health portfolio of innovative product technologies and surgical solutions for female stress urinary incontinence and pelvic organ prolapse.
Instead of tackling tumors head-on, an international team of researchers from the University of Geneva and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening with cellular receptor that is overexpressed specifically in cancer blood vessels.
› Verified 2 days ago
Dr. Karinna Hope Andrews, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3110 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-388-2068 Fax: 304-388-2437 | |
Dr. Stephen Harold Bush, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-388-1515 Fax: 304-388-1570 | |
Dr. Stephen Harold Bush Ii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Courtney Dr, Charleston, WV 25304 Phone: 304-925-4200 Fax: 304-925-0483 | |
Ms. Lauren Nicole Becker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Courtney Dr, Charleston, WV 25304 Phone: 304-925-7600 | |
Jessica L Matheny, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Courtney Dr, Charleston, WV 25304 Phone: 304-925-7600 Fax: 304-925-5892 | |
Mr. Robert Todd Depond, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Suite 304, Charleston, WV 25302 Phone: 304-388-1552 | |
Dr. David W Thomas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Ste 402, Charleston, WV 25302 Phone: 304-343-5736 Fax: 304-343-5271 |